PRICE T ROWE ASSOCIATES INC /MD/ - 30 Sep 2025 SCHEDULE 13G Report for BridgeBio Oncology Therapeutics Inc COMMON STOCK (BBOT)

Filing Manager: PRICE T ROWE ASSOCIATES INC /MD/
Reporting Manager: T. Rowe Price Associates, Inc.
Security: BridgeBio Oncology Therapeutics Inc COMMON STOCK
Symbol: BBOT
Shares outstanding: 80,458,364 shares
Disclosed Ownership: 885,042 shares
Ownership: 1.1%
Form type: SCHEDULE 13G
Filing time: 14 Nov 2025, 12:19:23 UTC
Date of event: 30 Sep 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
T. Rowe Price Associates, Inc.	1.1%	885,042	885,042	0	Ellen York	Vice President